Clinical Trials Browser

Withdrawn × Interventional × cilgavimab and tixagevimab drug combination × Clear all

NCT05465876 2024-04-04

PACE-CLL

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell